Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings

M Kannan, F Ahmad, R Saxena - Blood reviews, 2019 - Elsevier
Platelets play a major role in primary hemostasis and thrombus formation. After vascular
injury, platelets adhere to injured site and rapidly change their shape that switches the …

[HTML][HTML] Innate immune cells, major protagonists of sickle cell disease pathophysiology

S Allali, TT Maciel, O Hermine… - Haematologica, 2020 - ncbi.nlm.nih.gov
Sickle cell disease (SCD), considered the most common monogenic disease worldwide, is a
severe hemoglobin disorder. Although the genetic and molecular bases have long been …

Inflammation in sickle cell disease

N Conran, JD Belcher - Clinical hemorheology and …, 2018 - content.iospress.com
The primary β-globin gene mutation that causes sickle cell disease (SCD) has significant
pathophysiological consequences that result in hemolytic events and the induction of the …

The platelet NLRP3 inflammasome is upregulated in sickle cell disease via HMGB1/TLR4 and Bruton tyrosine kinase

S Vogel, T Arora, X Wang, L Mendelsohn… - Blood …, 2018 - ashpublications.org
A key inflammatory mechanism recently identified in platelets involves the Nod-like receptor
nucleotide-binding domain leucine-rich repeat containing protein 3 (NLRP3) and Bruton …

[HTML][HTML] The molecular basis for the prothrombotic state in sickle cell disease

AS Shet, MA Lizarralde-Iragorri, RP Naik - Haematologica, 2020 - ncbi.nlm.nih.gov
The genetic and molecular basis of sickle cell disease (SCD) has long been characterized
but the pathophysiological basis has not been entirely defined. How a red cell hemolytic …

Platelets at the crossroads of thrombosis, inflammation and haemolysis

S Vogel, SL Thein - British journal of haematology, 2018 - Wiley Online Library
Platelets play a critical role at the interphase of thrombosis and inflammation, key features in
haemolysis‐associated disorders. Exercising this role requires expression of pattern …

Hypercoagulable state in sickle cell disease

C Faes, EM Sparkenbaugh… - Clinical Hemorheology …, 2018 - content.iospress.com
Chronic activation of coagulation is one of the features of sickle cell disease (SCD).
Increased tissue factor expression, phosphatidylserine exposure, thrombin generation and …

Measuring success: utility of biomarkers in sickle cell disease clinical trials and care

R Kalpatthi, EM Novelli - Hematology 2014, the American …, 2018 - ashpublications.org
Progress in the care of sickle cell disease (SCD) has been hampered by the extreme
complexity of the SCD phenotype despite its monogenic inheritance. While epidemiological …

[HTML][HTML] Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia

RR Penkert, JL Hurwitz, P Thomas, J Rosch… - …, 2018 - ncbi.nlm.nih.gov
Children with sickle cell anemia (SCA) suffer from a chronic state of inflammation due to
repeated tissue insult from sickling red blood cells. The clinical consequences are severe …

Antibiotics for treating acute chest syndrome in people with sickle cell disease

AJ Marti-Carvajal, LO Conterno… - Cochrane Database …, 2019 - cochranelibrary.com
Background The clinical presentation of acute chest syndrome is similar whether due to
infectious or non‐infectious causes, thus antibiotics are usually prescribed to treat all …